Why is this medication prescribed?

Bezlotoxumab injection is prescribed to prevent Clostridium difficile infection (CDI) recurrence in adults who are at high risk for recurrence. CDI is a bacterial infection that can cause severe diarrhea and inflammation of the colon, often occurring after antibiotic use. Bezlotoxumab works by binding to and neutralizing the toxin produced by the bacteria, thereby reducing the risk of recurrence.

How should this medicine be used?

The injection is typically administered as a single dose through intravenous (IV) infusion over 60 minutes. It should be administered by a healthcare professional in a clinical setting. The dosage and frequency of administration will be determined by your healthcare provider based on your individual circumstances and risk factors. It’s essential to follow your healthcare provider’s instructions carefully regarding the administration of Bezlotoxumab to ensure its effectiveness and safety.

Other uses for this medicine

Bezlotoxumab injection is primarily used for preventing Clostridium difficile infection (CDI) recurrence in adults at high risk for recurrence. Currently, there are no other approved uses for Bezlotoxumab.

What special precautions should I follow?

As for special precautions, here are some important points to keep in mind:

• Allergic reactions: Inform your healthcare provider about any known allergies you have, especially if you’ve had a previous allergic reaction to Bezlotoxumab or any other medications. Bezlotoxumab injection may cause allergic reactions, including anaphylaxis, which can be severe and life-threatening.
• Medical history: Provide a comprehensive medical history to your healthcare provider before starting Bezlotoxumab treatment, especially if you have a history of certain medical conditions such as congestive heart failure or if you are immunocompromised.
• Pregnancy and breastfeeding: The safety of Bezlotoxumab during pregnancy and breastfeeding has not been established. Inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding, as they will need to weigh the potential benefits against the risks before prescribing Bezlotoxumab.
• Monitoring: Your healthcare provider may monitor you for any signs of infection or allergic reactions during and after Bezlotoxumab administration. Be sure to report any unusual symptoms or side effects promptly.
• Concomitant medications: Inform your healthcare provider about all medications, supplements, and herbal products you are taking, as Bezlotoxumab may interact with other medications. This includes any antibiotics you may be taking concurrently.
• Administration: Bezlotoxumab is administered as an intravenous infusion by a healthcare professional in a clinical setting. Follow your healthcare provider’s instructions carefully regarding the dosage, administration, and scheduling of Bezlotoxumab injections.

Always consult your healthcare provider for personalized advice and recommendations regarding the use of Bezlotoxumab, and do not hesitate to ask any questions or express any concerns you may have about the treatment.

What special dietary instructions should I follow?

Regarding special dietary instructions for Bezlotoxumab Injection, there are typically no specific dietary restrictions associated with its use. However, maintaining a balanced and healthy diet can support overall health and immune function, which may indirectly contribute to the prevention of Clostridium difficile infection recurrence.

What should I do if I forget a dose?

If you forget a dose of Bezlotoxumab Injection, contact your healthcare provider or clinic as soon as possible to reschedule the missed dose. It’s essential to adhere to the prescribed dosing schedule to maximize the effectiveness of Bezlotoxumab in preventing Clostridium difficile infection recurrence. Avoid doubling the dose to make up for a missed dose unless specifically instructed by your healthcare provider.

What side effects can this medication cause?

Bezlotoxumab Injection, like any medication, can cause side effects, although not everyone experiences them. Common side effects reported with Bezlotoxumab may include:

• Headache: Some individuals may experience headaches during or after the infusion.
• Nausea: Nausea or a feeling of unease in the stomach may occur.
• Fatigue: Feelings of tiredness or fatigue have been reported in some cases.
• Diarrhea: While Bezlotoxumab is used to prevent recurrent Clostridium difficile infection, diarrhea may still occur in some individuals.
• Fever: A low-grade fever or elevated body temperature may occur as a side effect.
• Infections: In rare cases, individuals may develop other infections, possibly due to immune system changes or underlying conditions.
• Allergic reactions: Although uncommon, allergic reactions can occur. Symptoms may include rash, itching, swelling, dizziness, or difficulty breathing.
• Infusion-related reactions: Some individuals may experience infusion-related reactions, such as chills or flushing, during or shortly after the infusion.

It’s essential to report any side effects to your healthcare provider promptly. While most side effects of Bezlotoxumab are mild and transient, some may require medical attention. If you experience severe or persistent side effects, contact your healthcare provider immediately.

This list is not exhaustive, and other side effects may occur. Additionally, individual responses to medications can vary, so not everyone will experience the same side effects. Your healthcare provider can provide more information about potential side effects specific to your situation.

What should I know about storage and disposal of this medication?

Storage and disposal of Bezlotoxumab Injection:

• Storage: Bezlotoxumab Injection should be stored in its original packaging at the recommended temperature, typically refrigerated between 2°C to 8°C (36°F to 46°F). Do not freeze. Protect the medication from light. Keep it out of reach of children and pets.
• Disposal: Dispose of any unused Bezlotoxumab Injection according to local regulations or guidelines provided by your healthcare provider or pharmacist. Do not dispose of medications in wastewater or household waste unless instructed to do so. Proper disposal helps prevent environmental contamination and accidental ingestion.

In case of emergency/overdose

In case of an emergency or suspected overdose with Bezlotoxumab Injection, seek immediate medical attention or contact a poison control center right away. Overdose symptoms may include severe allergic reactions, such as difficulty breathing, swelling of the face, lips, tongue, or throat, and severe dizziness or fainting. Be prepared to provide information about the medication, dosage, and any symptoms experienced.

What other information should I know?

• Inform all healthcare providers involved in your care about your Bezlotoxumab treatment to prevent potential interactions with other medications or procedures.
• Attend all scheduled appointments for Bezlotoxumab administration and follow-up evaluations as directed by your healthcare provider.
• Keep a record of your Bezlotoxumab treatments, including dates and dosages, for your own reference and to share with healthcare providers as needed.
• Follow your healthcare provider’s instructions regarding any dietary restrictions, lifestyle modifications, or additional medications that may be recommended during Bezlotoxumab treatment.

By understanding how to properly store, dispose of, and respond to emergencies related to Bezlotoxumab Injection, you can help ensure safe and effective use of the medication. Always consult your healthcare provider or pharmacist if you have any questions or concerns about Bezlotoxumab or its administration.